Name Dr Opeolu Oyejide Ojo
Job Title Senior Lecturer in Biotechnology
Faculty Faculty of Science and Engineering
School School of Sciences
Subject(s) Biotechnology
Tel 01902 322155
Email o.ojo2@wlv.ac.uk

Biology, Chemistry and Forensic Science

Before joining the University of Wolverhampton, Dr Ojo was a Lecturer in Biochemistry within the School of Health, Sport and Bioscience at the University of East London (UEL), Stratford, United Kingdom. He was also a Postdoctoral Research Associate in Diabetes Research at the University of Ulster, Coleraine, UK, where he completed his PhD studies in Experimental Diabetes. Dr. Ojo started his academic career in Nigeria as a Lecturer in Integrated Science at the Federal College of Education, Yola, Nigeria and was one of the pioneering scientist at the Chevron Biotechnology Centre at Federal University of Technology, Yola before relocating to the United Kingdom. 

 

Qualifications

PhD in Biomedical Sciences, University of Ulster, Coleraine, UK
MTech Biochemistry, Federal University of Technology, Yola, Nigeria
Postgraduate Diploma in Science Education, Federal University of Technology, Yola, Nigeria
B.Sc. Biochemistry, Obafemi Awolowo University, Ile-Ife, Nigeria 

Drug discovery, Diabetes, Natural products, Bioinformatics, Genomics and Proteomics

My research centres on drug discovery for the treatment of type 2 diabetes and understanding factors which contribute to the aetiology of the disease. Research themes include:

•Discovery, targets and actions of novel antidiabetic agents: Research under this theme will consolidate my existing research in drug development by focusing focus on the isolation and characterization of novel antidiabetic agents from natural sources and in silico design of hybrid peptides and novel analogues of endogenous and exogenous peptides with focus on elucidation of their sites and mode of actions and potential therapeutic roles in correcting insulin secretion in diabetes.

•Regulation of non-classical beta cell receptors and implications for the treatment of type 2 diabetes: Research under this theme focuses on investigations of the role of non-classical beta cell receptors (e.g. oestrogen receptors) on parameters such as beta cells secretory functions, proliferation, survival as well as understanding the role of environmental endocrine disruptors (such as bisphenol A, pesticides etc) on the development of type 2 diabetes and the development and assessment of therapeutic potentials of agonists/antagonists of oestrogen receptors

•Epigenetic factors in the development of type 2 diabetes: I am interested in using advanced genomic tools to understand environmental and genetic factors that predispose people from Black, Asian and Minority Ethnic (BAME) background to the development of type 2 diabetes.

Fellow, Higher Education Academy, UK
Fellow, Institute of Biomedical Sciences
Chartered Scientist, The Science Council, UK
Board Member, Biotechnology Society of Nigeria
Member, Royal Society of Chemistry
Member, Diabetes UK
Member, European Association for the Study of Diabetes
Member, European Society of Endocrinology
Member, European Peptide Society
Member, The Endocrine Society
Member, The Biochemical Society, United Kingdom
Member, American Society for Microbiology
Member, International Society for Adolescent and Paediatric Diabetes
Member, African Society for Bioinformatics and Computational Biology
Member, International Society for Bioinformatics and Computational Biology 

Published Articles

1. Vasu S, Ojo OO, Moffett RC, Conlon JM, Flatt PR, Abdel-Wahab YH (2017). Anti-diabetic actions of esculentin-2CHa (1–30) and its stable analogues in a diet-induced model of obesity-diabetes. Amino acids. 49(10):1705-17

2. Owolabi BO, Mudale V, Ojo OO, Moffett RC, McMahon MK, Curtis TM, Conlon JM, Flatt PR and Abdel-Wahab YH (2017). Actions of PGLa-AM1 and its [A14K] and [A20K] analogues and their therapeutic potential as anti-diabetic agents. Biochimie 138: 1-12

3. Owolabi BO, Ojo OO, Srinivasan DK, Conlon JM, Flatt PR and Abdel-Wahab YH (2016). Glucoregulatory, endocrine and morphological effects of [P5K] hymenochirin-1B in mice with diet-induced glucose intolerance and insulin resistance. Naunyn-Schmiedeberg's archives of pharmacology, 389(7): 769-781

4. Ojo OO, Srinivasan DK, Owolabi BO, McGahon MK, Moffett RC, Curtis TM, Conlon JM, Flatt PR, Abdel-Wahab YH (2016). Molecular mechanisms mediating the beneficial metabolic effects of [Arg4] tigerinin-1R in mice with diet-induced obesity and insulin resistance. Biological chemistry. Doi: 10.1515/hsz-2016-0120

5. Haggag Y, Abdel-Wahab Y, Ojo OO, Osman M, El-Gizawy S, El-Tanani M, Faheem A, McCarron P (2016). Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG. International journal of pharmaceutics. 29;499(1):236-246

6. Owolabi BO, Ojo OO, Srinivasan DK, Conlon JM, Flatt PR, Abdel-Wahab YH (2016). In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure–activity study. Amino acids. 48(2):535-47

7. Ojo OO, Srinivasan DK, Owolabi BO, Vasu S, Conlon JM, Flatt PR, Abdel-Wahab YH (2015). Esculentin-2CHa-Related peptides modulate islet cell function and improve glucose tolerance in mice with diet-induced obesity and insulin resistance. PLoS one.10(10):e0141549

8. Ojo OO, Ladeji O, Olayaki OO, Jide-Ojo CC (2015). Hepatoprotective and antioxidant efficacy of aqueous stem bark extracts of Balanites aegyptiaca (Linn.) Del. against acetaminophen induced liver injury in rats. Journal of Medicinal Herbs and Ethnomedicine. 27;1:89-96

9. Olayaki LA, Abduraheem TA, Mbukanma OE, Agbede OO, Salman TM and Ojo OO (2015). Short day photoperiod protects against acetaminophen-induced hepatotoxicity in rats. Nigerian Journal of Biotechnology, 29:56 - 62

10. Srinivasan DK, Ojo OO, Owolabi BO, Conlon JM, Flatt PR, Abdel-Wahab YHA (2015). [I10W] tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice. Acta diabetologica, 1-13. DOI:10.1007/s00592-015-0783-3

11. Olayaki LA, Irekpita JE, Yakubu MT, Ojo OO (2015). Methanolic extract of Moringa oleifera leaves improves glucose tolerance, glycogen synthesis and lipid metabolism in alloxan-induced diabetic rats. Journal of Basic and Clinical Physiology and Pharmacology. DOI:10.1515/jbcpp-2014-0129

12. Srinivasan D, Ojo OO, Owolabi BO, Conlon JM, Flatt PR, Abdel-Wahab YHA (2015). The frog skin host-defense peptide CPF-SE1 improves glucose tolerance, insulin sensitivity and islet function and decreases plasma lipids in high-fat fed mice. European Journal of Pharmacology, 764, 38-47

13. Sarno G, Daniele G, Tirabassi G, Chavez AO, Ojo OO, Orio F, Kahleova H, Balercia G, Grant WB, De Rosa B, Colao A, Muscogiuri, G. (2015). The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. Endocrine, 1-7

14. Ojo OO and Jide-Ojo C. C. (2015). Insulinotropic actions of acetone extracts of Moringa oleifera involve the induction of membrane depolarization and enhancement of intracellular calcium concentration in BRIN-BD11 clonal pancreatic cells. Journal of Experimental and Integrative Medicine 5(1): DOI: 10.5455/jeim.080115.or.117

15. Olayaki LA, Soladoye AO and Ojo OO (2015). Melatonin improves diabetes-induced foetal growth retardation in rats. Bangladesh Pharmaceutical Journal 18(1): 42-47

16. Ojo OO, Srinivasan DS, Owolabi BO, Flatt PR and Abdel-Wahab YHA (2015).Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes. Biochimie 109: 18-26

17. Ojo OO, Srinivasan DS, Owolabi BO, Flatt PR and Abdel-Wahab YHA (2015). Magainin-AM2 improves glucose homeostasis, and beta cell function in high fat fed mice. BBA General Subjects, 1850:80-87.

18. Hannan JMA, Ojo OO, Ali L, Rokeya B, Khaleque J, Akhter M, Flatt PR, Abdel-Wahab YHA (2015). Actions underlying antidiabetic effects of Ocimum sanctum leaf extracts in animal models of type 1 and type 2 diabetes. European Journal of Medicinal Plants, 5(1):1-12

19. Ojo OO, Srinivasan DS, Owolabi BO, Flatt PR and Abdel-Wahab YHA (2015). Magainin-related peptides stimulate insulin-release and improve glucose tolerance in high fat fed mice. Journal of Protein and Peptide Letters 22(3):256-263.

20. Thomson HAJ, Ojo OO, Flatt PR, Abdel-Wahab YHA (2014). Antidiabetic actions of aqueous bark extract of Swertia chirayita on insulin secretion, cellular glucose uptake and protein glycation. Journal of Experimental and Integrative Medicine 4:1-5

21. Ojo OO(2014). In vitro insulinotropic actions of various extracts of Moringa oleifera leaves. Nigerian Journal of Biotechnology, 27:14-20

22. Thomson HAJ, Ojo OO, Flatt PR and Abdel-Wahab YHA (2014). Aqueous bark extracts of Terminalia arjuna stimulates insulin release, enhances insulin action and inhibits starch digestion and protein glycation in vitro. Austin Journal of Endocrinology and Diabetes, 1:1-6.

23. Fatumo SA, Adoga MP, Ojo OO, Oluwagbemi O, Adeoye TA, Ewejobi I, Adebiyi M, Adebiyi E, Clement B, Oyekanmi, N (2014). Computational Biology and Bioinformatics in Nigeria. PLOS Computational Biology, 10 (4):E1003516 (1-7).

24. Srinivasan D, Ojo OO, Abdel-Wahab YH, Flatt PR, Guilhaudis L, Conlon JM. (2014). Insulin-releasing and cytotoxic properties of the frog skin peptide, tigerinin-1R: A structure-activity study. Peptides14: 43-46.

25. Ojo OO, Abdel-Wahab YHA, Flatt PR and Conlon JM. (2013). Insulinotropic actions of the frog skin host-defense peptide alyteserin-2a: a structure-activity study. Chemical Biology & Drug Design, 82 (2): 196-204

26. Ojo OO, Conlon JM, Flatt PR & Abdel-Wahab YHA. (2013). Frog skin peptides (tigerinin-1R, magainin-AM1, AM2, CPF-AM1 and PGla-AM1) stimulate secretion of glucagon-like peptide 1 (GLP-1) by GLUTa cells. Biochemistry Biophysics Research Communications, 431(1): 14-18

27. Jide-Ojo CC, Gungula DT and Ojo OO (2013). Extracts of Jatropha curcas L. exhibit significant insecticidal and grain protectant effects against maize weevil, Sitophilus Zeamais (Coleoptera: Curculionidae). Journal of Stored Products and Postharvest Research, 4(3): 44 -50.

28. Ojo OO, Abdel-Wahab YHA, Flatt PR, Mechkarska M and Conlon JM (2011). Tigerinin-1R: a potent, non-toxic insulin-releasing peptide isolated from the skin of the Asian frog, Hoplobatrachus rugulosus. Diabetes, Obesity and Metabolism, 13(12):1114-1122

29. Zahid OK, Mechkarska M, Ojo OO, Abdel-Wahab YHA, Flatt PR, Meetani MA, and Conlon JM (2011). Caerulein- and xenopsin-related peptides with insulin-releasing activities from skin secretions of the clawed frogs, Xenopus borealis and Xenopus amieti (Pipidae). General and comparative endocrinology. 172(2): 314-320

30. Jide-Ojo CC and Ojo OO (2011). Evaluation of the biological effects of leaf extracts of Jatropha curcas against Sitophilus zeamais (Coleoptera: Curculionidae). Electronic journal of environmental, agricultural and food chemistry. 10(5): 2166 – 2172

31. Mechkarska M, Ojo OO, Meetani MA, Coquet L, Jouenne T, Abdel-Wahab YHA, Flatt PR, King JD and Conlon JM (2011). Peptidomic analysis of skin secretions from the bullfrog Lithobates catesbeianus (Ranidae) identifies multiple peptides with potent insulin-releasing activity. Peptides, 32(2): 203 – 208

32. Ojo OO and Omabe M (2010). Incorporating bioinformatics into biological science education in Nigeria: Prospects and challenges. Infection, Genetics and Evolution. 11: 784 – 787

33. Tella IO, Ojo OO, Omijeh JE and Eronmosele, JE (2008). Control of streptozotocin-induced hyperglycaemia in rats using Psidium guajava extracts. Nigerian Journal of Biotechnology. 13: 32 – 38.

34. Omijeh JE, Ojo OO, Tella IO, and Eronmosele JE (2008). Aqueous extract of Anacardium occidentale reduces hyperglycaemia induced by streptozotocin in rats. Nigerian Journal of Biotechnology. 13: 24 – 29

35. Ayuba DK, Tella IO and Ojo OO (2008). Bioactive secondary plant compounds in the foliage and stem bark of Eucalyptus camaldulensis Dehn, grown in Yola, Adamawa State. Journal of Research in Bioscience, 4 (3):111 -117

36. Ayuba DK, Tella IO and Ojo OO (2008). Determination of infochemicals and the phytochemical screening of the foliage and stem-bark of Senna siamea (Lam.) grown in Yola, Adamawa State. International Journal of Bioscience, 3(2): 107 – 111

37. Ojo OO and Ladeji, O (2007). Prevention of paracetamol induced-oxidative stress by extracts of some common Nigeria Trees. Biological and Environmental Science Journal for the Tropics. 4 (1): 65 – 69

38. Ojo OO and Jide-Ojo CC (2007). Efficacy of the extracts of Cymbropogon citratus against acetaminophen-induced lipid peroxidation in rats. Nigerian Journal of Biotechnology, 12 (1): 34-39

39. Ojo OO, Ladeji O and Nadro MS (2007). Studies of the antioxidative effects of green and black tea (camellia sinensis) extracts in rats. Journal of medicinal foods, 10 (2): 373-378

40. Ojo OO, Kabutu RF, Bello LM and Babayo U (2006). Inhibition of paracetamol-induced oxidative stress in rats by extracts of lemongrass (cymbropogon citratus) and green tea (camellia sinensis). African Journal of Biotechnology. 5(12):1227 – 1232

41. Ojo OO, Nadro MS and Tella IO (2006). Protection of rats by extracts of some common Nigerian trees against acetaminophen-induced hepatotoxicity. African Journal of Biotechnology 5(9): 755- 760

42. Ojo OO, Jide-Ojo CC, Kabutu FR, Onyirioha N and Kyado SS (2006). Study of the antioxidative effects of lemon grass (Cymbropogon citratus) in rats. Nigerian Journal of Science, Technology and Environmental Education. 2: 51 – 57

43. Kabutu RF, Ojo OO, Kyado J and Onyirioha N (2006). Factors that control teachers’ effectiveness in teaching primary science. Journal of Science, Technology and Environmental Education, 2: 124 – 130

44. Ojo OO and Ladeji O (2005). Hepatoprotective and antioxidant effects of Camellia sinensis (Black tea) in rats. African Journal of Biotechnology, 4 (11): 1432-1438

45. Ojo OO, Tella IO and Ademola-Aremu OO (2005). Hepatoprotective effects of Azadirachtaindica, Tamarindus indica and Eucalyptus camaldulensis on paracetamol-induced hepatotoxicity in rats. Journal of Sustainable Development in Agriculture and Environment. 1 (1): 77-85

46. Tella IO and Ojo OO (2005). Effects of Azadirachta indica, Tamarindus indica and Eucalyptus camaldulensis on paracetamol-induced lipid peroxidation in rats. Journal of Sustainable Development in Agriculture and Environment. 1 (1): 86-95

47. Ojo OO, Kabutu RF and Kidah MI (2005). Assessment of the Effectiveness of micro-computer as a teaching material in teaching of sciences: A case study of Federal college of Education, Yola. Journal of General Studies in Education, 1: 8-12


Published Book Chapters

48. Ojo OO, Flatt PR, Abdel-Wahab YHA and Conlon JM (2013). Insulin-Releasing Peptides. In: Kastin AJ (Ed), Handbook of Biologically Active Peptides (2nd Edition). Oxford: Elsevier, pp. 364-370. ISBN 978-0-12-385095-9

49. Ojo OO (2013). Introduction to Bioinformatics. In: Ogbonna JC, Ubi BE, Eweani IB (Eds), Fundamental, Industrial and Medical Biotechnology. A publication of Biotechnology Society of Nigeria, Beijing: Universal Academic Services, pp78 – 118. ISBN 978-978-993-166-6



Patent
50. Abdel-Wahab, Y.H.A., Flatt, PR.,Ojo, OO and Conlon, J.C. Esculentin-2CHa peptide and analogues thereof. Filed on 31 January 2014 under UK Patent Application No. 1401673.7


Conference Presentations, Abstracts and Short Communications

51. YHA Abdel-Wahab, V Musale, BO Owolabi, RC Moffett, OO Ojo, JM Conlon and PR Flatt (2017). [A14K] PGLa-AM1: mechanisms underlying beneficial actions on pancreatic beta cells in vitro and high fat diet induced Type 2 diabetes in vivo. Diabetic Medicine 34(S1), P97. Conference Information: Diabetes UK Annual Professional Conference, March 8 – 10, 2017 Manchester, England (Poster).

52. OO Ojo, WA Ofosu, O Osoba, Z Iqbal, IC Suciu, ML Mehnaz and CC Ojo (2017). Gallic acid stimulates insulin secretion in a dose-dependent manner from clonal pancreatic cells, BRIN-BD11. Diabetic Medicine 34(S1), P98. Conference Information: Diabetes UK Annual Professional Conference, March 8 – 10, 2017 Manchester, England (Poster)

53. WA Ofosu, CE Maduekwe, J Beinarovica and OO Ojo (2017). In vitro investigation of the insulinotropic actions of the green tea polyphenol, epigallocatechin galate (EGCG). Diabetic Medicine 34(S1), P99. Conference Information: Diabetes UK Annual Professional Conference, March 8 – 10, 2017 Manchester, England (Poster).

54. Delivery of a 1-day seminar on Strategic partnership and fund sourcing for research in Africa; Obafemi Awolowo University, Ile-Ife, Nigeria; September 02, 2016

55. Plenary Lecture on “Bioinformatics in modern biotechnology research and development: prospect and challenges”. 29th annual conference of the Biotechnology Society of Nigeria; University of Calabar, Nigeria; August 28 – 31, 2016

56. Facilitation of a 5-day training workshop on the application of biotechniques to medicinal plant research; Obafemi Awolowo University, Ile-Ife, Nigeria; July 18 – 23, 2016

57. Poster presentation on “In vitro and in vivo insulin-releasing activities of cyclohexane extracts of Tamarindus indica leaves. Diabates UK Annual Professional Conference, March 2 – 4, 2016

58. Oral presentation “[Lys14]PGLa-AM1: A novel peptide analogue with insulinotropic and anti-hyperglycemic effects on high fat fed mice. Diabetes UK Annual Professional Conference, March 11 -13, 2015

59. Owolabi BO, Ojo OO, Flatt PR and Abdel-Wahab YHA (2014). [Lys5]-substitution enhanced the insulinotropic effects of hymenochrin-1B isolated from the skin secretion of Hymenochirus boettgeri. Irish Journal of Medical Science183(9):S449-S450. Conference Information:Irish Endocrine 39th Annual Meeting, November 14-15, 2014, Galway, Republic of Ireland (Poster).

60. Abdel-Wahab YHA, Ojo OO, Owolabi BO, Conlon JM and Flatt PR (2014). [Lys-4]-substitution of the frog skin peptide, caerulein precursor fragment-AM1 (CPF-AM1), enhances its insulin-releasing properties in vitro. Diabetic Medicine31(1), P74. Conference Information: Diabetes UK Annual Professional Conference, March 5 – 7, 2014 Liverpool, England (Poster)

61. Ojo OO, Srinivasan DS, Owolabi OB, Conlon JM, Flatt PR, Abdel-Wahab YHA (2014). Frog Skin Peptide (CPF-AM1) for the treatment of type 2 diabetes. Conference Information : SET for BRITAIN at House of Commons, London 17 March, 2014 (Poster)

62. Haggag Y, Ojo OO, Abdel-Wahab Y, Osman M, McCaron P, Faheem A (2014). Preparation, characterization and in vivo evaluation of insulin-loaded PLGA-PEG nanoparticles for controlled delivery. Conference Information: Joint Schools of Pharmacy Research Seminar, April 14-15, 2014, Trinity College, Dublin (Poster).

63. Ojo OO, Owolabi BO, Usman MU, Jide-Ojo CC (2013). Amphibian skin peptides: A new paradigm in type 2 diabetes treatment. Conference Information: 26th Annual conference of the Biotechnology Society of Nigeria, August 26 -30, 2013, Abuja, Nigeria (Oral).

64. Ojo OO, Adeyemo OO, Adedeji BO, Njobdi S, Mujeli M, Jelani FB, Jide-Ojo CC (2013). Applications of proteomics techniques to bioresources exploration and exploitation in Nigeria. Conference Information: 26th Annual conference of the Biotechnology Society of Nigeria, August 26 -30, 2013, Abuja, Nigeria. (Oral)

65. Ojo OO, Conlon JM, Flatt PR, Abdel-Wahab YHA. (2012). Caerulein precursor fragment-AM1 (CPF-AM1): A novel non-toxic insulin-releasing peptide isolated from the skin secretions of the clawed frog, Xenopus amieti .Endocr. Rev. 33(03): MON 109 Conference Information: 94th Annual Meeting and Expo of the Endocrine Society, June 23 – 26, Houston, Texas, USA (Poster)

66. Ojo OO, Conlon JM, Flatt PR, Abdel-Wahab YHA (2012). Evaluation of the in vitro and in vivo insulinotropic and glucose-lowering effects of Caerulein Precursor Fragment (CPF-AM1) isolated from the skin secretion of the clawed frog, Xenopus amieti. 2nd Irish Peptide Workshop, p. 35 Conference Information: 2nd Irish Peptide Workshop, June 14 – 15, 2012, Coleraine, United Kingdom (Poster)

67. Srinivasan DS, Ojo OO, Flatt PR, Conlon JM, Abdel-Wahab YHA (2012). [Lys-3] substitution of peptide Alyteserin-2a from skin secretions of the midwife toad Alytes obstetricians enhances insulin-releasing activity in vitro. 2nd Irish Peptide Workshop, p. 40 Conference Information: 2nd Irish Peptide Workshop, June 14 – 15, 2012, Coleraine, United Kingdom (Poster)
68. Ojo OO, Conlon JM, Flatt PR, Abdel-Wahab YHA (2012). Caerulein precursor fragment (CPF-AM1): a novel insulinotropic peptide from the skin secretion of the clawed frog, Xenopus amieti. Conference Information: 15th International and 14th European Congress of Endocrinology, May 05 – 09, 2012, Florence, Italy (Oral)

69. Abdel-Wahab YHA,Ojo OO, Flatt PR, Conlon JM (2011). Tigerinin-1R from the skin secretions of Vietnamese Frog Hoplobatrachus rugulosus, exerts potent insulinotropic effects both in vitro and in vivo. Diabetologia 54: S193 Conference Information: 47th Annual Meeting of the European Society for the Study of Diabetes, September 12 -16, 2011, Lisbon, Portugal (Poster)
70. Ojo OO, Cara D, Hewage C, Flatt PR, Abdel-Wahab YHA(2011). Extracts of Tinospora cordifolia stimulate insulin release and inhibit protein glycation in vitro. Conference Information : 3rd Annual Translational Medicine Conference, May 5 -6, 2011, Derry, Northern Ireland (Poster)

71. Ojo OO, Conlon JM, Flatt PR, Abdel-Wahab YHA (2011). Insulinotropic effects of caerulin precursor fragment (CPF-AM1) isolated from the skin secretion of the clawed frog, Xenopus amieti. Irish Journal of Medical Science, 180: Supplement 13: S481 Conference Information: 35th Annual Meeting of the Irish Endocrine Society, November 11-12, 2011, TemplePatrick, Northern Ireland (Oral)
72. Ojo OO, Flatt PR, Conlon JM, Abdel-Wahab, YHA (2010). Isolation and structural characterization of novel insulinotropic peptides from skin secretions of Xenopus amieti. Regulatory Peptides, 164 (1, Sp. Iss. SI). pp. 36-37. Conference Information: 18th International Symposium on Regulatory Peptide, September 5 – 8, 2010, Belfast, UK (Poster)

73. Ojo OO (2009). Incorporating bioinformatics into biological science education in Nigeria: Problems and prospects. Conference Information: Annual Meeting of The International Society for Computational Biology (ISCB) and The African Society for Bioinformatics and Computational Biology (ASBCB), November 30 – December 03, 2009, Bamako, Mali (Oral).